NCT03554772View on ClinicalTrials.gov

Efficacy, Tolerability, Safety, and Pharmacokinetic Study of DFN-15

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 19, 2018

Primary Completion Date

August 20, 2018

Study Completion Date

August 20, 2018

Conditions
Acute Pain
Interventions
DRUG

DFN-15 (Celecoxib Oral Solution) 62.5 mg

Oral Solution

DRUG

DFN-15 (Celecoxib Oral Solution) 125 mg

Oral Solution

DRUG

DFN-15 (Celecoxib Oral Solution) 250 mg

Oral Solution

DRUG

Placebo

Oral Solution

Trial Locations (1)

84124

Site 101, Salt Lake City

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY